Financial Performance - The company's operating revenue for Q1 2023 was ¥1,236,596,013.53, representing an increase of 18.66% compared to the same period last year[4] - Net profit attributable to shareholders was ¥166,520,090.53, reflecting an increase of 8.69% year-on-year[4] - The net profit for Q1 2023 was CNY 166,520,090.53, an increase of 8.6% compared to CNY 153,203,982.25 in Q1 2022[19] - Operating profit for Q1 2023 reached CNY 198,426,538.66, up from CNY 187,394,576.30 in the same period last year, reflecting a growth of 6.1%[19] - Total revenue from operating activities amounted to CNY 1,099,498,014.86, compared to CNY 821,270,785.11 in Q1 2022, indicating a significant increase of 34%[21] - Total revenue for Q1 2023 reached ¥1,236,596,013.53, an increase of 18.6% compared to ¥1,042,152,720.94 in Q1 2022[17] Cash Flow and Investments - The net cash flow from operating activities reached ¥210,561,918.95, showing a significant increase of 642.49% compared to the previous year[4] - Cash flow from operating activities showed a net inflow of CNY 210,561,918.95, a turnaround from a net outflow of CNY -38,813,883.36 in Q1 2022[21] - Investment activities generated a net cash outflow of CNY -164,943,991.10, compared to CNY -98,152,854.78 in the previous year, reflecting increased investment activities[22] - The company reported cash and cash equivalents at the end of Q1 2023 totaling CNY 1,203,910,256.34, up from CNY 569,953,519.22 at the end of Q1 2022[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥8,930,331,690.45, up 1.66% from the end of the previous year[4] - Current assets totaled ¥5,447,562,092.77 as of March 31, 2023, compared to ¥5,320,914,051.87 at the end of 2022, marking an increase of 2.4%[13] - Non-current assets amounted to ¥3,482,769,597.68, up from ¥3,463,338,478.06, indicating a growth of 0.6%[14] - Total liabilities decreased to ¥1,802,253,625.27 from ¥1,822,573,049.80, a reduction of 1.1%[16] - Shareholders' equity increased to ¥7,128,078,065.18, up from ¥6,961,679,480.13, reflecting a growth of 2.4%[16] Earnings and Shareholder Information - Basic and diluted earnings per share were both ¥0.25, a decrease of 3.85% from the same period last year[4] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.25, slightly down from CNY 0.26 in Q1 2022[20] - The number of ordinary shareholders at the end of the reporting period was 64,706, with the largest shareholder holding 19.50% of the shares[9] Other Income and Expenses - Non-operating income totaled ¥12,004,561.74 after tax impacts, with significant contributions from government subsidies and investment income[5] - Investment income increased by 1,130.98% due to higher returns from structured deposits[7] - The company recorded a significant increase in investment income, reaching CNY 6,515,358.27 compared to CNY 529,282.18 in the previous year[19] - Research and development expenses decreased to CNY 30,947,488.73 from CNY 33,596,760.33, a reduction of approximately 7.9%[19] Inventory and Current Assets - The company reported a decrease of 76.76% in other current assets due to a reduction in deductible VAT input tax[7] - Inventory decreased to ¥1,149,678,867.25 from ¥1,209,908,569.25, a decline of 4.9%[13] - Cash and cash equivalents rose to ¥1,378,886,187.30 from ¥1,352,049,912.52, an increase of 2.0%[13]
山东药玻(600529) - 2023 Q1 - 季度财报